LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product lifecycle, today announced an ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch1 of Acetylcysteine Injection, 6 gm/30 mL ...

This new product will be available in the strength of 6 gm/30 mL (200 mg/mL) single-dose vials in the US market, marking an ...

The carmaker announced a new $6 billion share repurchase program. GM also raised its dividend 25%, although the yield remains low. Massive buybacks have helped drive its stock price higher.

and Instagram (glenmark_pharma). 1Glenmark's Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials is only approved for the indication(s) listed in Glenmark's approved label.

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the acquisition and launch of acetylcysteine injection, 6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s acetylcysteine injection, 6 gm/30 ...